All In Biotech

Drug Trial Radar · NCT07253428

Emergence Agitation

IMPACT OF SUGAMADEX ON AGITATION UPON EMERGENCE FOLLOWING ADULT NASAL SURGERIES.

Last checked: Nov 20, 2026Latest source record: Nov 28, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruitingPivotal-lookingRandomized with 486 participants. This is a heuristic, not a regulatory label.

Status

Active, not recruiting

Enrollment

486

Planned (sponsor's estimate)

Start

Oct 30, 2025

Primary completion

Dec 31, 2025

Study completion Jan 31, 2026

Sponsor

Lead sponsor
Ain Shams UniversityAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Nov 28, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Prevention
FDA-regulated drug
No
Who can join
All sexes, from 18 years, up to 60 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The impact of sugammadex on agitation upon emergence following adult nasal surgeries is an issue which needs to be studied that links anesthetic management with postoperative recovery.

Conditions

  • Emergence Agitation
  • Nasal Surgery

Interventions

  • Neostigmine + AtropineDrug

    Neostigmine group will receive the neostigmine as a reversal of the muscle relaxant; rocuronium

  • SugamadexDrug

    Sugamadex group will receive sugamadex as a reversal agent of the muscle relaxant; rocuronium Neostigmine group will receive the neostigmine as a reversal of the muscle relaxant; rocuronium. Both interventions will be used to compare the effect of adequate muscle relaxation upon the emergence agitation.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. the incidence of emergence agitation following adult nasal surgeries in patients receiving sugammadex versus a traditional neuromuscular blocking agent reversal method.Time frame: perioperative

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Rabah Alharbi

    Ha'il, Saudi Arabia

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.